Denmark: Aphria and Schroll Medical partner to produce medical cannabis
Canadian medical cannabis producer Aphria has announced that it has signed a strategic partnership with Schroll Medical, a Danish subsidiary of flower producer Schroll Flowers, one of Europe's largest producers and distributors of hydrangeas.
The partnership aims to produce and distribute organic and GMP cannabis throughout Europe.
Aphria paid 160,000$ Canadian for 15% of the partnership, a relatively low price for this kind of partnership, with the possibility of going up to 50%.
Schroll hopes to produce 3000kg of dried flowers per year. The company already owns 3,000m² of greenhouses and has already begun construction of an extraction plant to transform the flowers into various concentrates.
While production will be entrusted to Schroll as part of a 4-year regulation of medical cannabis in Denmark, Aphria's German subsidiary will manage the partnership as a consultant for GMP certification, cannabis varieties and genetics, and intellectual property for cultivation methods.
Aphria now has the capacity to produce and distribute cannabis in all legal markets, with export licenses in Canada, Jamaica, Africa and soon Colombia. As for the Danish partnership, its proximity to the German market will enable it to gain market share in the European medical market.
Aphria production sites
The United States Bans «Non-Natural» Synthetic Cannabinoids; THC Remains Legal Until December 11
Morocco's first CBD medication for epilepsy hits pharmacy shelves
November 2026's CBD Highlights: 10 Flowers and Rosins to Discover from 5 French Producers
Vanuatu is still trying to get its medical cannabis sector off the ground after years of delays
Snoop Dogg Opens His Cannabis Club in Barcelona
In Texas, Democrats and Republicans are beginning to find common ground on the legalization of cannabis
Proposition 215, 30 Years Later: When Cannabis in California Was a Movement, Not an Industry
Village Farms Expands Cannabis Production in the Netherlands while its European Business Jumps by 75%
Bedrocan's bankruptcy delays medical cannabis reform in the Netherlands
Where to Buy Affordable CBD in 2026? Our Tips for Making the Right Choice
-
Business3 weeks agoCronos Completes the Acquisition of CanAdelaar for 57.5 million euros
-
Cannabis in France4 weeks ago
France already has 3,000 cannabis retail outlets. None of them are legal.
-
Cannabis in Quebec2 weeks ago
Cannabis: What France Could Learn from Quebec, Eight Years After Legalization
-
Cannabis in the U.S.4 weeks ago
A DEA report confirms that there are no fatal cannabis overdoses
-
Business4 weeks ago
Tilray is accelerating its operations in Europe thanks to a license in Portugal
-
Cannabis in New Zealand2 weeks ago
Chronic Pain: New Zealand Is Testing Cannabis to Improve Sleep
-
CBD4 weeks ago
October 2026 CBD Highlights: 10 Strains and Hash to Discover from 5 French Producers
-
Cannabis in Morocco4 weeks ago
Morocco: Three Cannabis-Based Medications Approved for the Treatment of Epilepsy
You must be logged in to post a comment Login